Over 500,000 strokes occur in this country annually, causing significant disability and death. Only one treatment, recombinant tissue plasminogen activator (rt-PA), is currently approved for stroke. However, just about 3% of the patients receive it, probably because the time-window for therapy is brief (3 hours or less). Therefore, there is a great need for effective neuroprotective agents that could be given alone or in conjunction with thrombolytic agents. Furthermore, prophylactic neuroprotective use may be indicated in certain clinical settings. Each year, in the United States alone, 600,000 adults and 12,000 children undergo open heart operations utilizing cardiopulmonary bypass, during which the brain is subjected to periods of ischemia. Despite advances in surgical procedures and shortening of the ischemic event, CNS dysfunction remains a leading cause of morbidity and mortality in these patients. Because the exact timing of the ischemic insult is known ahead of time in these patients, the potential exists to significantly reduce myocardial damage by pre-treatment with agents that protect the brain from ischemia-reperfusion damage prior to surgery. Our HYPOTHESIS is that select protein kinase C (PKC) isozymes play an important (positive and/or negative) role in the various stages of response of the brain to ischemic insult. Using isozyme-specific inhibitor and activator peptides that we have developed, we plan to; determine which PKC isozymes are activated following cerebral ischemia and when does that occur, and determine whether inhibition or activation of these isozymes can provide protection from ischemic reperfusion damage to the brain. These studies will demonstrate the effectiveness of in vivo delivery of PKC regulating peptides for the treatment of ischemic reperfusion injury of the CNS. Should the treatment be found efficacious and safe, these peptide regulators of PKC activity may be useful for the treatment of stroke and brain ischemia in humans.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
1R01NS044350-01A1
Application #
6619256
Study Section
Special Emphasis Panel (ZRG1-BDCN-1 (01))
Program Officer
Jacobs, Tom P
Project Start
2003-02-01
Project End
2007-01-31
Budget Start
2003-02-01
Budget End
2004-01-31
Support Year
1
Fiscal Year
2003
Total Cost
$336,997
Indirect Cost
Name
Stanford University
Department
Biology
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
CastaƱeda, Dora; Zhao, Heng; Mochly-Rosen, Daria et al. (2009) Activating deltaPKC antagonizes the protective effect of ERK1/2 inhibition against stroke in rats. Brain Res 1251:256-61
Bright, Rachel; Sun, Guo-Hua; Yenari, Midori A et al. (2008) epsilonPKC confers acute tolerance to cerebral ischemic reperfusion injury. Neurosci Lett 441:120-4
Qi, Xin; Mochly-Rosen, Daria (2008) The PKCdelta -Abl complex communicates ER stress to the mitochondria - an essential step in subsequent apoptosis. J Cell Sci 121:804-13
Qi, Xin; Inagaki, Koichi; Sobel, Raymond A et al. (2008) Sustained pharmacological inhibition of deltaPKC protects against hypertensive encephalopathy through prevention of blood-brain barrier breakdown in rats. J Clin Invest 118:173-82
Bright, Rachel; Steinberg, Gary K; Mochly-Rosen, Daria (2007) DeltaPKC mediates microcerebrovascular dysfunction in acute ischemia and in chronic hypertensive stress in vivo. Brain Res 1144:146-55
Battaini, Fiorenzo; Mochly-Rosen, Daria (2007) Happy birthday protein kinase C: past, present and future of a superfamily. Pharmacol Res 55:461-6
Shimohata, Takayoshi; Zhao, Heng; Sung, Jae Hoon et al. (2007) Suppression of deltaPKC activation after focal cerebral ischemia contributes to the protective effect of hypothermia. J Cereb Blood Flow Metab 27:1463-75
Wang, Jian; Bright, Rachel; Mochly-Rosen, Daria et al. (2004) Cell-specific role for epsilon- and betaI-protein kinase C isozymes in protecting cortical neurons and astrocytes from ischemia-like injury. Neuropharmacology 47:136-45
Bright, Rachel; Raval, Ami P; Dembner, Jeffrey M et al. (2004) Protein kinase C delta mediates cerebral reperfusion injury in vivo. J Neurosci 24:6880-8